JAFL
Jay A. Fishman Ltd Portfolio holdings
AUM
$1.04B
1-Year Return
20.25%
This Quarter Return
+14.41%
1 Year Return
+20.25%
3 Year Return
+102.32%
5 Year Return
+197.1%
10 Year Return
+481.9%
AUM
$825M
AUM Growth
+$42.3M
(+5.4%)
Cap. Flow
-$54.7M
Cap. Flow
% of AUM
-6.62%
Top 10 Holdings %
Top 10 Hldgs %
67.92%
Holding
103
New
10
Increased
17
Reduced
46
Closed
5
Top Buys
| 1 |
Comerica
CMA
|
$11.4M |
| 2 |
Merck
MRK
|
$4.98M |
| 3 |
Zoetis
ZTS
|
$2.55M |
| 4 |
Icahn Enterprises
IEP
|
$1.88M |
| 5 |
Eli Lilly
LLY
|
$1.8M |
Top Sells
| 1 |
Apple
AAPL
|
$18.4M |
| 2 |
AbbVie
ABBV
|
$12.6M |
| 3 |
JPMorgan Chase
JPM
|
$6.49M |
| 4 |
Johnson & Johnson
JNJ
|
$5.01M |
| 5 |
Blackstone
BX
|
$3.5M |
Sector Composition
| 1 | Technology | 34.33% |
| 2 | Financials | 14.39% |
| 3 | Industrials | 12.41% |
| 4 | Healthcare | 12.15% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Tyra Biosciences
TYRA
$647M
| $375K | 0.05% |
22,000
| – | – |
|
77
iShares Biotechnology ETF
IBB
$5.68B
| $373K | 0.05% |
2,940
| – | – |
|
78
Village Farms International
VFF
$300M
| $345K | 0.04% |
575,400
| – | – |
|
79
TSMC
TSM
$1.22T
| $340K | 0.04% |
3,367
| – | – |
|
80
Intuit
INTU
$186B
| $335K | 0.04% |
732
| – | – |
|
81
Eagle Materials
EXP
$7.55B
| $317K | 0.04% |
1,700
| – | – |
|
82
PJT Partners
PJT
$4.37B
| $280K | 0.03% |
4,026
-17,892
| -82% | -$1.25M |
|
83
Rivian
RIVN
$16.6B
| $268K | 0.03% |
16,072
| – | – |
|
84
Marriott International Class A Common Stock
MAR
$73B
| $266K | 0.03% |
1,450
-250
| -15% | -$45.9K |
|
|
SHYF
85
DELISTED
The Shyft Group
SHYF
| $265K | 0.03% |
12,000
+2,000
| +20% | +$44.1K |
|
86
Exxon Mobil
XOM
$479B
| $264K | 0.03% |
+2,462
| New | +$264K |
|
87
Extra Space Storage
EXR
$30.5B
| $260K | 0.03% |
1,750
| – | – |
|
88
Procter & Gamble
PG
$373B
| $254K | 0.03% |
1,675
-126
| -7% | -$19.1K |
|
89
Cigna
CI
$81.2B
| $247K | 0.03% |
+881
| New | +$247K |
|
90
MSCI
MSCI
$43.1B
| $244K | 0.03% |
520
| – | – |
|
91
Goldman Sachs
GS
$227B
| $228K | 0.03% |
+706
| New | +$228K |
|
92
Dow Inc
DOW
$16.9B
| $213K | 0.03% |
+4,000
| New | +$213K |
|
93
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $203K | 0.02% |
+1,225
| New | +$203K |
|
94
PMV Pharmaceuticals
PMVP
$76.3M
| $188K | 0.02% |
30,000
+5,000
| +20% | +$31.3K |
|
95
Relay Therapeutics
RLAY
$690M
| $126K | 0.02% |
10,000
| – | – |
|
96
Tango Therapeutics
TNGX
$760M
| $66.4K | 0.01% |
20,000
+10,000
| +100% | +$33.2K |
|
|
GOEV
97
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $49.1K | 0.01% |
223
| – | – |
|
98
Bristol-Myers Squibb
BMY
$95B
| – | – |
-28,377
| Closed | -$1.97M |
|
99
DocuSign
DOCU
$15.4B
| – | – |
-10,425
| Closed | -$608K |
|
100
iShares MSCI Emerging Markets ETF
EEM
$19B
| – | – |
-10,300
| Closed | -$406K |
|